A Prospective, Multi-Centered, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-Related Morbidity and All-Cause Mortality in Adult Patients with Aneuri